名称 | AI-Edigene® FGFR3(E17)-TACC3(E10) Fusion |
型号 | CBP20200R |
报价 | |
特点 | AI-Edigene® FGFR3(E17)-TACC3(E10) Fusion |
产品搜索
相关文章
联系我们
联系人:蒋经理
电话:4008750250
号码:
手机:18066071954
地址:南京市栖霞区纬地路9号
Email: zhangxiangwen@cobioer.com
电话:4008750250
号码:
手机:18066071954
地址:南京市栖霞区纬地路9号
Email: zhangxiangwen@cobioer.com
产品展示 / PRODUCTS
- 详细内容
CBP20200R | |
Format | RNA |
Description | FGFR3-TACC3 results from the fusion of FGFR3 and TACC3, demonstrating constitutive kinase activity, transforming activity in culture and ability to drive tumor growth in xenografts (PMID: 25294908, PMID: 22837387). FGFR3-TACC3 has been identified in lung adenocarcinoma and glioblastoma (PMID: 25294908, PMID: 22837387). |
Technical Data | |
Left Gene | FGFR3 |
Left Breakpoint | chr4:1808661:+ |
Right Gene | TACC3 |
Right Breakpoint | chr4:1739325:+ |
Cosmic ID | COSF1434 |
Buffer | RNase-free H2O |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purity | Download for COA |
RNA electrophoresis | Download for COA |
Sanger sequencing | |
Storage | -80℃ |
Expiry | 12 months from the date of manufacture |